Fulgent Genetics (FLGT) Long-Term Investments (2017 - 2026)
Fulgent Genetics' Long-Term Investments history spans 10 years, with the latest figure at $328.3 million for Q1 2026.
- On a quarterly basis, Long-Term Investments fell 33.56% to $328.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $328.3 million, a 33.56% decrease, with the full-year FY2025 number at $369.3 million, down 35.26% from a year prior.
- Long-Term Investments hit $328.3 million in Q1 2026 for Fulgent Genetics, down from $369.3 million in the prior quarter.
- Over the last five years, Long-Term Investments for FLGT hit a ceiling of $602.2 million in Q3 2024 and a floor of $326.6 million in Q4 2022.
- Historically, Long-Term Investments has averaged $439.5 million across 5 years, with a median of $415.6 million in 2022.
- Biggest five-year swings in Long-Term Investments: soared 71.47% in 2022 and later crashed 35.26% in 2025.
- Tracing FLGT's Long-Term Investments over 5 years: stood at $326.6 million in 2022, then increased by 29.67% to $423.6 million in 2023, then soared by 34.65% to $570.4 million in 2024, then crashed by 35.26% to $369.3 million in 2025, then fell by 11.1% to $328.3 million in 2026.
- Business Quant data shows Long-Term Investments for FLGT at $328.3 million in Q1 2026, $369.3 million in Q4 2025, and $411.8 million in Q3 2025.